Proteus Seeks Pharma Partnerships For Ingestible Sensor

The firm recently gained the first FDA clearance for a medication adherence indication, an important milestone for Proteus Digital Health's plan to get its device incorporated directly into pharmaceutical products to measure whether a patient is taking the drug as directed.

Proteus Digital Health Inc. says it is working with FDA and pharmaceutical manufacturers to further integrate its Ingestible Sensor directly into prescribed pharmaceuticals following the recent FDA clearance of the product specifically for monitoring patients' medication adherence.

Marketing a specific drug with the sensor will require an additional new drug application filing, but the medication-adherence is an...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Archive

More from Medtech Insight